Skip to main content
Clinical Trials/JPRN-UMIN000020037
JPRN-UMIN000020037
Unknown
未知

Comparison of the efficacy and safety of dulaglutide in combination with insulin compared with insulin alone in daibetes patients who are receiving high dose glucocorticoids therapy: a randomized,open-label trial - Comparison of the efficacy and safety of dulaglutide in combination with insulin compared with insulin alone in daibetes patients who are receiving high dose glucocorticoids therapy: a randomized,open-label trial

Kanagawa Cardiovascular and Respiratory Center0 sites30 target enrollmentDecember 2, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Diabetes mellitus
Sponsor
Kanagawa Cardiovascular and Respiratory Center
Enrollment
30
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 2, 2015
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1Patients less than 20 years old or 80 years of age or more 2Patients who are pregnant, breastfeeding or may become pregnant 3Type 1 diabetes mellitus patients 4Insulin\-dependent diabetes mellitus patients 5Patients with severe infection or severe trauma 6Patients with severe hepatic disease 7Patients with severe renal disease 8Patients with hypopituitarism and/or adrenal insufficiency 9Patients with severe gastroenteric disturbance as exemplified by severe gastro\-paresis. 10Patients with a history of pancreatitis 11Patients with malnutrition 12Patients taking DPP4\-I,SGLT2I,GLP1 receptor agonists except for dulaglutide 13Patients who considered not eligible for the study by the attending doctor due to other reasons

Outcomes

Primary Outcomes

Not specified

Similar Trials